Market Place
Sourcing Support
FDA approves record eight biosimilars in H1 2024; okays first interchangeable biosimilars for Eylea
Biologics, or complex drugs that are derived from living organisms, have revolutionized treatment of
Endocrinology Newsmakers: Drugmakers work on triple agonist treatments, gene therapies to fight diabetes
Endocrinology, a medicinal
branch that deals with endocrine and metabolic disorders, is witnessing
